Aurora Cannabis (ACB.US) stock plunged more than 6.0% after the company reported lower than expected Q3 figures. Cannabis producers lost 85 Canadian cents per share, while analysts expected a much smaller loss of 21 Canadian cents per share. Revenue of 55.161 million Canadian dollars also came in below estimates for 66.92 million Canadian dollars. Medical cannabis net sales rose 17% however adult-use cannabis sales dropped 53%. Aurora attributed the drop in recreational weed sales partially due to pandemic-related restrictions in Canada. Separately, Aurora announced a move in its U.S. stock listing to Nasdaq from the New York Stock Exchange, citing lower costs.
Aurora Cannabis (ACB.US) stock launched today's session with a bearish price gap and is approaching the lower limit of the descending channel which coincides with local support at $6.55. Should break lower occur, then downward move may be extended to the next support at $3.80. On the other hand, if buyers will manage to halt decline here, then upward impulse towards resistance at $9.25 could be launched. Source: xStation5
Start investing today or test a free demo
Open account Try demo Download mobile app Download mobile appThis content has been created by XTB S.A. This service is provided by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, entered in the register of entrepreneurs of the National Court Register (Krajowy Rejestr Sądowy) conducted by District Court for the Capital City of Warsaw, XII Commercial Division of the National Court Register under KRS number 0000217580, REGON number 015803782 and Tax Identification Number (NIP) 527-24-43-955, with the fully paid up share capital in the amount of PLN 5.869.181,75. XTB S.A. conducts brokerage activities on the basis of the license granted by Polish Securities and Exchange Commission on 8th November 2005 No. DDM-M-4021-57-1/2005 and is supervised by Polish Supervision Authority.
